论文部分内容阅读
流感是由流感病毒引起的一种危害人类健康的急性呼吸道传染病,发病率占有所呼吸道传染病的首位,往往造成季节性全球或局部地区大流行。流感还可引起很多合并症,如继发细菌感染,引起咽喉炎、中耳炎、鼻窦炎和支气管炎。严重感染者可引起病毒性肺炎,尤其是对老年人、慢性病人和小孩。流感还可使原有的慢性病加重,包括心脏病、肺病、肾脏疾病和糖尿病,可导致相应器官功能的衰竭。盐酸阿比朵尔(Arbidol)是前苏联药物化学研究中心(ALL—Russian Chem.Pharm.Res.lnst莫斯科)研制的抗病毒新药,成为治疗流感的“重磅炸弹”。盐酸阿比朵尔是用于治疗和预防由A、B型流感病毒引起的流感及急性呼吸道病毒感染,且具有抗病毒、呼吸道合胞病毒的新型抗病毒药物。于1993年在俄罗斯首次上市,用于防治流行性感冒和其它急性呼吸道病毒感。
Influenza is a kind of acute respiratory disease caused by the influenza virus which is endangering human health. The incidence of influenza is the top priority of respiratory diseases, which often cause seasonal global or regional pandemic. Flu can also cause a lot of complications, such as secondary bacterial infections, cause pharyngitis, otitis media, sinusitis and bronchitis. Severe infections can cause viral pneumonia, especially in the elderly, chronic patients and children. The flu can also aggravate the original chronic disease, including heart disease, lung disease, kidney disease and diabetes, can lead to the failure of the corresponding organ function. Arbidol hydrochloride is an antiviral drug developed by the former Soviet Union Center for Medicinal Chemistry (ALL-Russian Chem. Pharm.Res.lnst Moscow) and became the “blockbuster” for the treatment of influenza. Arbidol hydrochloride is a novel antiviral drug used to treat and prevent influenza and acute respiratory virus infections caused by influenza A and B viruses and has antiviral and respiratory syncytial virus. It was first introduced in Russia in 1993 for the prevention and control of influenza and other acute respiratory virus infections.